The Sontag Foundation
Overview
The Sontag Foundation is a private foundation that invests in brain cancer research through grants and venture philanthropy, focusing on early-career scientists and early-stage technologies to accelerate cures.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Alpheus Medical | May 2025 | Series B | Co-investor |
| AiM Medical Robotics | Sep 2025 | Series A | Co-investor |
| Myosin Therapeutics Inc. | Feb 2025 | Seed | Co-investor |
| Cordance Medical | Nov 2025 | Seed | Co-investor |
| FYR Diagnostics | Sep 2025 | VC Round | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is The Sontag Foundation based?
The Sontag Foundation is headquartered in Ponte Vedra Beach, Florida, United States.
When was The Sontag Foundation founded?
The Sontag Foundation was founded in 2002.
How many portfolio companies does The Sontag Foundation have?
The Sontag Foundation has 8 portfolio companies in Caplight's dataset.
What are some companies in The Sontag Foundation's portfolio?
Portfolio companies visible on Caplight include Alpheus Medical, AiM Medical Robotics, Myosin Therapeutics Inc., Cordance Medical, FYR Diagnostics.
What was The Sontag Foundation's most recent investment shown here?
The Sontag Foundation's most recent investment in this portfolio sample was in Cordance Medical in 2025.
What sectors does The Sontag Foundation focus on?
The Sontag Foundation focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does The Sontag Foundation focus on?
The Sontag Foundation typically invests at the Early stage.
What is The Sontag Foundation's AUM?
The Sontag Foundation's assets under management are estimated between $187.4M and $219.6M.